Abstract: A system in accordance with an example includes a first load and a second load. The first load includes a first power supply connected to a first uninterruptible power supply (UPS). The second load includes a second power supply connected to a second UPS, where the first UPS is connected to the second UPS. The first power supply is to deliver power to the first load and to the second load when power to the second load is disabled, and the second power supply is to deliver power to the second load and to the first load when power to the first load is disabled.

Abstract: An air-bearing surface of a slider is coated with a photoresist having a high optical absorbance at or near an operational wavelength of the slider. Light is directed at a target wavelength through an entry of a waveguide integrated into the slider. The light exiting the waveguide forms a feature through the photoresist, the feature proximate a near-field transducer of the slider. A sub-micron pattern is formed using the feature.

Abstract: Described herein is certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.

Abstract: An artificial disc is provided which more closely matches the movement of the natural spine. The artificial disc uses one or more projections and corresponding recesses to provide a sliding articulation. The artificial joint is inherently stable in that compressive forces placed on the disc such as the weight placed upon the joint or the tension of surrounding tissues urges the joint towards a neutral position and not farther away from a neutral position.

Abstract: Described herein is certain crystalline forms of Compound 5, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.

Abstract: Described are examples of back-up power apparatuses and systems including such back-up power apparatuses. An example may include a battery module, and a back-up power control module to determine a back-up power demand of a host device and selectively enable an output of power from the battery module to the host device if the battery module has a power capacity greater than the back-up power demand.

Abstract: One disclosed aspect of the embodiments is an apparatus to hold a mobile device in a vehicle. A sleeve is stretchable to fit longitudinally along a sun visor of a vehicle and having front and back surfaces. The front surface has a vent structure. A first strap is transversely attached on the front surface at a first side of the vent structure to hold a first end of a first device. A second strap is transversely attached on the front surface at a second side of the vent structure to adjustably hold a second end of the first device. The second side is opposite to the first side across the vent structure.

Abstract: The present invention relates to a method of preparing an aqueous dispersion of polymer encapsulated particulate material, the method comprising: providing a dispersion of the particulate material in a continuous aqueous phase, the dispersion comprising ethylenically unsaturated monomer and a stabilizer for the particulate material; and polymerizing the ethylenically unsaturated monomer by non-living free radical polymerization to form polymer that encapsulates the particulate material, thereby providing the aqueous dispersion of polymer encapsulated particulate material; wherein polymerization of the ethylenically unsaturated monomer comprises: (a) polymerizing a monomer composition that includes ionizable ethylenically unsaturated monomer so as to form a base responsive water swellable non-living polymer layer that encapsulates the particulate material; and (b) polymerizing a monomer composition that includes non-ionizable ethylenically unsaturated monomer so as to form an extensible, water and base permeab

Abstract: Described herein are certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.

Abstract: Access to documents by parties can be controlled as follows. First, access can be controlled in accordance with access counters associated with the parties, where the documents have one or more versions. Second, access can be controlled in accordance with access levels associated with the parties. The access level of each party is one of a first access level, a second access level, a third access level, or a fourth access level. The first, second, third, and fourth access levels are ordered from the first access level to the fourth access level such that the first access level provides a greatest degree of access to the documents and the fourth access level provides a least degree of access to the documents. Third, access can be controlled in accordance with placement of organizations within a hierarchy of organizations, where the parties are organized over the organizations.

Abstract: A bottom hole assembly used for a field operation is disclosed herein. The bottom hole assembly can include at least one directional antenna disposed on an outer surface of a first tubing pipe of a tubing string, where the at least one directional antenna receives a first electric current from at least one power source, where the first electric current generates a first magnetic field that radiates from the at least one directional antenna into a formation. The bottom hole assembly can also include at least one receiver disposed on a second tubing pipe of the tubing string, where the at least one receiver receives the first magnetic field returning from the formation.

Abstract: Examples disclose an uninterruptible power supply comprising an integrated circuit. The integrated circuit comprises a charger to charge a battery and an inverter to deliver output power from the battery to a load. The integrated circuit further comprises an active filter to reduce input current to the uninterruptible power supply by compensating a power factor corresponding to input power.

Abstract: A strip of material for the delivery of an oral care active is disclosed. The strip of material includes a structural elastic-like film backing layer including a strainable network having a first region and a second region formed of substantially the same material composition, the first region providing a first, elastic-like resistive force to an applied axial elongation, and the second region providing a second distinctive resistive force to further applied axial elongation, thereby providing at least two stages of resistive forces in use; and an oral care composition disposed on the film, the oral care composition including an oral care active.

Abstract: A grilling oven for foodstuffs comprising an oven casing having rows of apertures/gaps in the lower section uniformly facing various directions. The grilling oven has three layers disposed apart from each other by the supporting bars attached to the plates/grids in the bottom-to-the-top order. The plates/grids include the plate/grid containing the burning materials, the plate/grid is used to scatter and increase the heat and prevent the fat and nutritious juices from overflowing to the burning materials, the plate/grid containing the foodstuff to be grilled. These plates/grids and supporting bars are removable from the oven casing since the diameters of the plates/grids are smaller than the internal diameter of the oven wall. The oven cover has various rows of ventilation holes disposed uniformly throughout the cover to adjust and guide—distribute the heat in contact with the foodstuff more uniformly so that the foodstuff will not be burnt out.

Abstract: Adaptors for providing a connection between fiber-optic cables may be configured to be interlocked in both side-by-side and top-to-bottom orientations with adjacent adaptors to eliminate wasted spaced between adjacent rows and/or columns of adaptors in a junction panel.

Abstract: Implantable prosthetic valves are disclosed, methods of their use, and related fabrication techniques are disclosed. In some cases, the prosthetic valves disclosed herein can include frame, skirt, and valve components. The frame component can have an overall, generally scalloped shape comprising fewer struts and fabricated from less raw material than known frames. In some cases, the prosthetic valves disclosed herein can be crimped to a smaller diameter than can other known valves.

Abstract: An artificial disc is provided which more closely matches the movement of the natural spine. The artificial disc uses one or more projections and corresponding recesses to provide a sliding articulation. The artificial joint is inherently stable in that compressive forces placed on the disc such as the weight placed upon the joint or the tension of surrounding tissues urges the joint towards a neutral position and not farther away from a neutral position.

Abstract: The present invention provides novel compounds of any one of Formulae (I)-(III), and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I)-(III) and pharmaceutical compositions thereof that are mucus penetrating. The invention also provides methods and kits for using the inventive compounds, and pharmaceutical compositions thereof, for treating and/or preventing diseases associated with abnormal or pathological angiogenesis and/or aberrant signaling of a growth factor (e.g., vascular endothelial growth factor (VEGF)), such as proliferative diseases (e.g., cancers, benign neoplasms, inflammatory diseases, autoimmune diseases) and ocular diseases (e.g., macular degeneration, glaucoma, diabetic retinopathy, retinoblastoma, edema, uveitis, dry eye, blepharitis, and post-surgical inflammation) in a subject in need thereof.

Abstract: Examples disclose a system with a first power module with a first switch to deliver power to a load by connecting the first switch. Further, the examples provide the system with a second power module with a second switch to deliver the power to the load by connecting the second switch, the power to the load from either the first power module or the second power module. Additionally, the examples also disclose a battery to provide voltage to either the first power module or the second power module to enable the delivery of the power to the load by alternating between the first switch in the first module and the second switch in the second power module.